GPC1 and neoplasm: The difference in molecular response to anti-GPC1 mAb treatment between monocultured and co-cultured lung fibroblasts and tumor cells implicates that anti-GPC1 mAb impairs the reciprocal crosstalk between tumor cells and tumor-associated fibroblasts.